HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.

Abstract
Deleted in Liver Cancer 1 (DLC1) is a tumour suppressor that encodes a RhoGTPase-activating protein (RhoGAP) and is frequently inactivated in many human cancers. The RhoGAP activity of DLC1 against Rho signalling is well documented and is strongly associated with the tumour suppressor functions of DLC1. However, the mechanism by which the RhoGAP activity of DLC1 is regulated remains obscure. Here, we report that phosphorylation of DLC1 at Ser549 by cyclic AMP-dependent protein kinase A contributes to enhanced RhoGAP activity and promotes the activation of DLC1, which suppresses hepatoma cell growth, motility and metastasis in both in vitro and in vivo models. Intriguingly, we found that Ser549 phosphorylation induces the dimerization of DLC1 and that inducible dimerization of DLC1 can rescue the tumour suppressive and RhoGAP activities of DLC1 containing a Ser549 deletion. Our study establishes a novel regulatory mechanism for DLC1 RhoGAP activity via dimerization induced by protein kinase A signalling.
AuthorsFrankie Chi Fat Ko, Lo-Kong Chan, Karen Man-Fong Sze, Yin-Shan Yeung, Edith Yuk-Ting Tse, Ping Lu, Ming-Hua Yu, Irene Oi-Lin Ng, Judy Wai Ping Yam
JournalNature communications (Nat Commun) Vol. 4 Pg. 1618 ( 2013) ISSN: 2041-1723 [Electronic] England
PMID23511482 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DLC1 protein, human
  • GTPase-Activating Proteins
  • Tumor Suppressor Proteins
  • rho GTPase-activating protein
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Animals
  • Cell Transformation, Neoplastic
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Dimerization
  • GTPase-Activating Proteins (chemistry, physiology)
  • HEK293 Cells
  • Humans
  • Mice
  • Neoplasm Metastasis
  • Phosphorylation
  • Transplantation, Heterologous
  • Tumor Suppressor Proteins (chemistry, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: